AEM vs CDE

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

CDE presents a stark dichotomy between explosive fundamental growth and bearish market sentiment. The company maintains a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.11. While the current price of $19.31 is significantly above the Graham Number ($10.5), it remains below the growth-based intrinsic value of $28.02. However, the bullish fundamental growth is heavily countered by a 0/100 technical trend and bearish insider sentiment.